ברקלוד 1 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

ENTECAVIR 1 MG

Disponible desde:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

Código ATC:

J05AF10

formulario farmacéutico:

FILM COATED TABLETS

Vía de administración:

PER OS

Fabricado por:

BRISTOL MYERS SQUIBB SPA, ITALY

Grupo terapéutico:

ENTECAVIR

indicaciones terapéuticas:

Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.

Fecha de autorización:

2009-02-01